top of page
Search

Stop Chasing Control. Start Building Confidence.

  • Writer: Sarah Sink
    Sarah Sink
  • 6 days ago
  • 3 min read

In drug development, there is a natural instinct to seek control.


Control over timelines.

Control over process performance.

Control over analytical outcomes.

Control over manufacturing and sterile fill finish execution.


It makes sense. These programs are complex, high-stakes, and resource-intensive.


But control, in the way many teams think about it, is rarely sustainable.


The programs that move forward successfully are not the ones that maintain perfect control. They are the ones that build confidence in how they operate.



Why Control Feels Necessary


Early in a program, teams work hard to create structure.


Processes are designed.

Analytical methods are developed.

Manufacturing plans are created.

Fill-finish strategies are outlined.


This creates a sense of control. Everything appears defined and predictable.


But as the program progresses, new data emerges. Variability appears. Operational realities introduce constraints.


The more complex the program becomes, the harder it is to maintain that initial sense of control.



Where Control Breaks Down


Control tends to break down at predictable points.


Scale-up introduces variability.

Tech transfer reveals differences between sites.

Analytical methods evolve.

Sterile fill finish introduces constraints around container systems, scheduling, and aseptic processes.


None of this is unexpected.


What matters is how teams respond when control begins to shift.


Programs that depend on rigid plans struggle to adapt. Programs that build confidence in their decision-making continue to move forward.



Confidence Is What Sustains Execution


Confidence is not about having perfect information.


It is about knowing how to move forward when information is still evolving.


Strong programs build confidence by:

  • Involving SMEs early

  • Aligning development, manufacturing, and fill finish perspectives

  • Creating clear decision frameworks

  • Communicating openly as data evolves


This allows teams to make decisions without hesitation, even when conditions change.


Confidence replaces the need for rigid control.



Sterile Fill Finish Highlights the Difference


Sterile fill finish is often where the difference between control and confidence becomes most visible.


At this stage, timelines are tight and execution must be precise. Container closure decisions, filtration strategies, and scheduling constraints all require coordination across teams.


If a program relies on control, changes at this stage feel disruptive.


If a program is built on confidence, teams adapt quickly. They understand the implications of changes and can make informed decisions without hesitation.


Fill finish does not introduce uncertainty. It reveals how prepared teams are to handle it.



The Role of CDMO Partnerships


CDMO partnerships play a critical role in building confidence.


Strong partners do not promise perfect control.


They provide clarity.

They share insights early.

They communicate risks transparently.

They support decision-making with context.

They align development, manufacturing, and fill finish activities.


From a business development perspective, this is what differentiates strong partnerships.


Confidence is built when teams trust not only the capability, but how challenges will be handled.



Business Development as a Confidence Builder


Business development professionals are often the bridge between expectation and execution.


They help set realistic timelines. They guide early conversations. They ensure that partners understand how work will actually unfold.


Strong business development professionals focus on building confidence from the start.


They do not rely on overly optimistic projections.


They create alignment, encourage transparency, and help teams prepare for change.


This is what allows programs to move forward with clarity.



What Strong Programs Do Differently


Programs that maintain momentum tend to share a few characteristics:

  • They accept that uncertainty is part of development

  • They build decision frameworks that support adaptability

  • They involve SMEs across development, manufacturing, and fill finish

  • They communicate openly as conditions evolve

  • They prioritize informed decisions over rigid control


These programs move forward because they are prepared to adapt.



Final Thoughts


Control in drug development is temporary.


Confidence is what lasts.


The programs that succeed are not those that avoid change. They are the ones that are prepared to navigate it.


If your team is evaluating CDMOs or comparing proposals, it is worth looking beyond capabilities and timelines. Consider how partners build confidence across development, manufacturing, and sterile fill finish.


My guide, How to Compare CDMO Quotes: 10 Factors Beyond Cost, helps biotech teams evaluate partners based on how well they support alignment, communication, and execution in real-world conditions.


Because the teams that move forward are not chasing control. They are building confidence.



For more insights and personalized support in navigating the biotech-CDMO landscape, visit www.yourpharmagirl.com and follow Your Pharma Girl on LinkedIn. Whether you need strategic guidance, tailored business development solutions, or expert advice on building lasting partnerships, I am here to help you and your team succeed at every stage of development.

 
 
 

Comments


bottom of page